Market Capitalization (Millions $) |
26 |
Shares
Outstanding (Millions) |
16 |
Employees |
- |
Revenues (TTM) (Millions $) |
1 |
Net Income (TTM) (Millions $) |
-20 |
Cash Flow (TTM) (Millions $) |
8 |
Capital Exp. (TTM) (Millions $) |
0 |
Cyclo Therapeutics Inc
Cyclo Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for rare diseases. The company utilizes a proprietary drug delivery technology called Trappsol Cyclo to develop treatments for various diseases that currently have limited or no treatment options. Cyclo Therapeutics is primarily focused on developing therapies for diseases that affect the central nervous system, including diseases such as Niemann-Pick Disease Type C (NPC), Alzheimer's disease, and stroke. The company's goal is to improve the lives of patients with rare diseases by providing effective and safe therapies that can potentially slow down or halt the progression of these diseases.
Company Address: 6714 NW 16th Street, Suite B Gainesville 32653 FL
Company Phone Number: 418-8060 Stock Exchange / Ticker: NASDAQ CYTH
|